Literature DB >> 274100

Induction of murine erythroleukemia cells to differentiate: a model for the detection of new anti-tumor drugs.

P A Marks, R Reuben, E Epner, R Breslow, W Cobb, A E Bogden, R A Rifkind.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 274100

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN： 0066-4758


× No keyword cloud information.
  3 in total

1.  Distribution, elimination, metabolism and bioavailability of hexamethylenebisacetamide in rats.

Authors:  C L Litterst; J S Roth; J A Kelley
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

2.  Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis.

Authors:  W Ketchart; K M Smith; T Krupka; B M Wittmann; Y Hu; P A Rayman; Y Q Doughman; J M Albert; X Bai; J H Finke; Y Xu; A A Exner; M M Montano
Journal:  Oncogene       Date:  2012-09-10       Impact factor: 9.867

Review 3.  Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.

Authors:  P A Marks; R A Rifkind
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.